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a b s t r a c t
Protein kinase C (PKC) that transduces signals to modulate a wide range of cellular functions has been
shown to regulate a number of viral infections. Herein, we showed that inhibition of PKC with the PKC
inhibitor GF109203X signiﬁcantly impaired porcine reproductive and respiratory syndrome virus
(PRRSV) replication. Inhibition of PKC led to virus yield reduction, which was associated with decreased
viral RNA synthesis and lowered virus protein expression. And this inhibitory effect by PKC inhibitor was
shown to occur at the early stage of PRRSV infection. Subsequently, we found that PRRSV infection
activated PKCδ in PAMs and knockdown of PKCδ by small interfering RNA (siRNA) suppressed PRRSV
replication, suggesting that novel PKCδ may play an important factor in PRRSV replication. Taken
together, these data imply that PKC is involved in PRRSV infection and beneﬁcial to PRRSV replication,
extending our understanding of PRRSV replication.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Porcine reproductive and respiratory syndrome (PRRS) is the
cause of a complex systemic disease in pigs, most notably affecting
the respiratory and reproductive systems of infected hosts, and
leading to signiﬁcant economic losses in the swine industry
worldwide (Collins et al., 1992; Meulenberg, 2000; Wensvoort et
al., 1991). The causative agent, PRRS virus (PRRSV), is an enveloped
single stranded positive-sense RNA virus belonging to the family
Arteriviridae in the order Nidovirales (Thiel et al., 1993). Recently, a
highly pathogenic PRRSV (HP-PRRSV) has emerged in China and
affected more than 20 million pigs (Tian et al., 2007).
PRRSV genome is approximately 15.4 kb, containing at least 10
open reading frames (ORF1a, ORF1b, ORF2a, ORF2b, and ORFs
3 through 7, including ORF5a). ORF1a and ORF1b encode poly-
proteins that are processed to at least 14 non-structural proteins
(nsps) by viral proteases, whereas the remaining ORFs in the 30
terminal region code for 8 structural proteins including GP2, small
envelope (E), GP3, GP4, 5a, GP5, membrane (M), and nucleocapsid
(N) (Conzelmann et al., 1993; Johnson et al., 2011).
Viruses utilize host signaling pathways to help their replication.
Bovine foamy virus activates NF-κB pathway to enhance viral
transcription (Wang et al., 2010), and mouse hepatitis virus, porcine
circovirus type 2, enterovirus 71, junín virus and dengue virus have
been shown to manipulate the host ERK signaling pathway to
regulate viral replication and gene expression (Cai et al., 2007;
Rodriguez et al., 2014; Smith et al., 2014; Wang et al., 2012; Wei
and Liu, 2009). JNK and p38 MAPK pathways contribute to coxsackie
virus B3, porcine circovirus type 2 (PCV2) and infectious bursal
disease virus infections (Si et al., 2005; Wei et al., 2011; Wei et al.,
2009). It has been reported that PRRSV infection induces ERK, JNK
and p38 MAPK activations in cultured cells and these signaling
pathways play important roles in PRRSV replication (Lee and Lee,
2010, 2012). However, whether other signaling pathways contribute
to PRRSV replication remains to be investigated.
Protein kinase C (PKC) comprises a family of serine/threonine
kinases with at least 12 members divided into three subgroups
based on their structures and requirements for activation. Classical
PKCs (cPKC: PKCα, PKCβI, PKCβII and PKCγ) require calcium and
diacylglycerol (DAG) for activation. Novel PKCs (nPKC: PKCδ, PKCε,
PKCη and PKCθ) depend only on DAG, and atypical PKCs (aPKC:
PKCζ, PKCλ, PKCμ and PKCι) are independent of DAG and calcium.
PKC plays a central role in diverse cellular processes and signal
transduction pathways that control cell proliferation, migration,
differentiation and apoptosis (Griner and Kazanietz, 2007;
Mochly-Rosen et al., 2012). For virus infections, PKC are involved
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in virus replication cycle, including entry, replication, and release
(Contreras et al., 2012; Filone et al., 2010; Hoffmann et al., 2008;
Kudoh et al., 2014; Sieczkarski et al., 2003). Of these, novel PKCs
(nPKC) isoform PKCδ is a very attractive cellular cofactor for virus
infection. For example, PKCδ has been reported to regulate HIV-1
replication at an early post-entry step by altering the actin cytoske-
leton in macrophages. In this report, the authors showed that
inhibition of PKCδ altered the redistribution of actin which is
required at the early reverse transcription, right after the initiation
of viral cDNA synthesis (Contreras et al., 2012). Moreover, PKCδ can
regulate replication and budding of respiratory syncytial virus
through PKCδ/hypoxia-inducible factor-1α/NF-κB signaling pathway
(Masaki et al., 2011). Apoptosis has been shown to be regulated by
PKCδ during infection with Sindbis Virus (SV) and avian reovirus
(ARV). Although the relationship between viral replication and
apoptotic responses regulated by PKCδ has not been studied, these
reports suggest that PKCδ-mediated anti- or pro-apoptotic responses
may inﬂuence viral replication (Lin et al., 2009; Zrachia et al., 2002).
In the present study, we investigated the roles of protein kinase
C (PKC) in PRRSV replication. Our results demonstrated that PKC
was essential for efﬁcient PRRSV replication and played a critical
role at early steps of infection. Moreover, we showed that PKCδ
isoform was involved in PRRSV replication.
Results
PRRSV replication is impaired by PKC inhibitor GF109203X
In order to investigate the biological importance of PKC in the
replication of PRRSV, a highly speciﬁc inhibitor of all the PKC
isoforms GF109203X was used and viral production was analyzed.
As shown in Fig. 1A (upper panel) and Fig. 1B, about 100-fold
reductions in HV (a HP-PRRSV strain) growth was observed in
the presence of 10 μM GF109203X when compared with the cells
treated with DMSO control. To further investigate whether this
inhibitory effect is strain-dependent, a similar experiment was
performed with the CH-1a strain in Marc-145 cells. As shown in
Fig. 1A (lower panel) and Fig. 1C, GF109203X showed a stronger
inhibitory effect against CH-1a replication in Marc-145 cells, and
about 104-fold suppression was observed at the concentration of
10 μM, indicating that GF109203X can inhibit PRRSV replication in
both PAMs and Marc-145 cells. PKC inhibitor GF109203X impaired
PRRSV replication with 50% effective concentration (EC50) values
of 4.59 μM for HV strain in PAMs and 2.89 μM for CH-1a strain in
Marc-145 cells. These data suggest that PKC might play an
important role in PRRSV replication.
To rule out the possibility that the reduced viral growth is due
to the cytotoxic effect of the inhibitor, cell viability for PAMs and
Marc-145 cells in the presence of various concentrations of
GF109203X or DMSO was analyzed using MTT assay. As shown
in Fig. 1D, no obvious cellular toxicity was observed at 48 h after
treatment with GF109203X at the indicated doses (5 and 10 μM).
The 50% cytotoxic concentrations (CC50) of GF109203X for PAMs
and Marc-145 cells were 29.79 μM and 22.24 μM, respectively,
which greatly exceeds its EC50.
Inhibition of PKC reduces viral RNA synthesis, protein expression, and
viral progeny production
We next investigated the kinetics of GF109203X-mediated
inhibition of PRRSV RNA synthesis and virus yield. PAMs were
Fig. 1. PRRSV propagation is impaired by treatment with GF109203X. The inhibitory effect of GF109203X (an inhibitor of all PKCs) was examined against the HP-PRRSV strain HV
and traditional PRRSV strain CH-1a in PAMs and Marc-145 cells, respectively. Cells were pretreated with GF109203X at indicated concentrations or DMSO for 1 h prior to infection
andwere then infected with PRRSV at an MOI of 0.3. GF109203X or DMSO was present in the medium throughout the infection. Cells infected with PRRSV and treated with porcine
IFNα (10 units/ml) were served as a positive control. (A) Indirect immunoﬂuorescence assay (IFA) was performed to detect PRRSV N protein at 24 hpi for HV and 36 hpi for CH-1a.
Upper panels: HV in PAMs; lower panels: CH-1a in Marc-145 cells. (B and C) The experiments were performed as in panel A and culture supernatants were collected for virus
titration. (D) Effect of GF109203X on PAMs and Marc-145 cells viability compared to the viability of DMSO-treated cells (set up as 1) was determined by MTT assay. The data
represent the mean7standard deviation from three independent experiments. Statistical signiﬁcance was analyzed by t-test; nPo0.05, nnPo0.01, nnnPo0.001 and nnnnPo0.0001.
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cultured either in the presence or absence of GF109203X and
infected with HV. Compared with DMSO-treated cells, the addition
of 10 μM GF109203X resulted in a signiﬁcant reduction of viral
RNA copies and this reduction reached a peak of more than 40-fold
at 24 h following GF109203X addition (Fig. 2A), and the virus titer
was decreased to 4.57105 TCID50/ml from 2.78107 TCID50/ml
(DMSO-treated control) in the presence of 10 μM GF109203X at
24 hpi (Fig. 2B).
We also examined PRRSV GP5 expression in PAMs infected
with PRRSV in the presence or absence of GF109203X. As shown in
Fig. 2C, GP5 protein expression was signiﬁcantly repressed in the
presence of 10 μM GF109203X, while a moderate reduction in
protein expression was observed at 5 μM GF109203X. These
ﬁndings suggest that PKC is required for PRRSV replication.
Inhibition of PKC reduces PRRSV replication at early steps
of the virus infection
To further assess which stage GF109203X acts on during PRRSV
infection, PAMs were treated with GF109203X at various time
points post-infection. As shown in Fig. 3A, cells treated with
GF109203X up to 2 h after the time of infection resulted in about
94–85% decrease in HV replication compared to the DMSO-treated
control. Addition of the inhibitor at 6 hpi and 12 hpi also reduced
the production of PRRSV by 70% and 30%, respectively (Fig. 3A).
We also examined the kinetics of GF109203X activity against
CH-1a replication in Marc-145 cells using time-of-addition assays
(Fig. 3B). Similarly, a signiﬁcant reduction in CH-1a production was
also observed when GF109203X was added at 1, 0, and 2 hpi.
Addition of GF109203X at 6 hpi and 12 hpi, virus replication was
also suppressed, but to lesser extents. In contrast, no signiﬁcant
reduction of viral production was observed when GF109203X was
added at 24 hpi in Marc-145 cells. These results indicate that the
inhibitory effect of GF109203X on PRRSV propagation is mainly at
early stages of the virus replication cycle.
Inhibition of PKC partially inhibits PRRSV entry
Next, we sought to investigate whether inhibition of PKC affects
the earliest step such as PRRSV entry. PRRSV entry is broadly
divided into two major steps: (i) virus attachment and receptor
binding, followed by (ii) receptor-mediated endocytosis and inter-
nalization. To address this issue, the binding and internalization
assays were performed as described previously on Marc-145 cells
(Yang et al., 2013). Our results showed that treatment with
GF109203X had slight effects on virus replication when added
during the period of virus attachment, suggesting that GF109203X
has little effect on PRRSV attachment to Marc-145 cells (Fig. 3C
and D).
To test whether GF109203X inhibits PRRSV internalization, we
examined the inhibitory effect of GF109203X against PRRSV
replication using virus internalization assay. As shown in Fig. 3E,
treatment with GF109203X during the ﬁrst 5 h of the virus
internalization process resulted in a 17-fold reduction of viral
RNA copies while a 3.5-fold decrease was observed when
GF109203X was added 3–5 h following temperature switch. We
also analyzed the production of PRRSV infectious progeny in
culture supernatants of GF109203X-treated Marc-145 cells. As
shown in Fig. 3F, when GF109203X was added 0–5 h following
temperature switch, the virus titer was decreased about 2 log 10,
and when GF109203X was added at 3 hpi the reduction in CH-1a
titer was less than 1 log 10 (about 4-fold decrease). These results
indicate that GF109203X partially blocks the events in PRRSV
entry that is downstream of cell attachment.
PKCδ is required for PRRSV replication
GF109203X is a pan PKC kinase inhibitor. To investigate which
speciﬁc PKC subgroups or isoforms are involved in PRRSV replication,
we investigated the effects of selective PKC inhibitors. As shown in
Fig. 4A, rottlerin (5 μM), a speciﬁc PKCδ inhibitor (Gschwendt et al.,
1994), strongly blocked HV replication, whereas Gö6976, a classical
PKC inhibitor, which inhibits PKC-α, β and γ, had limited effects on
HV replication. The cell viability in the presence of various concen-
trations of rottlerin or DMSO was analyzed using MTT assay (Fig. 4C),
showing that there was no observable cellular toxicity after treat-
ment with the inhibitor rottlerin at the indicated dose. Similar results
were got with CH-1a on Marc-145 cells (data not shown). We
observed a slight inhibition of HV replication by Gö6976 at a
concentration of 5 μM or 10 μM, while cell viability was strongly
affected by Gö6976 at the concentration of 5 μM (data not shown).
Given that rottlerin inhibits PRRSV replication as effectively as
GF109203X, we speculate that PKCδ might be the main PKC isoform
required for PRRSV replication.
To further conﬁrm this, we next used small interfering RNA
(siRNA) to see if knockdown of PKCδ could affect PRRSV replica-
tion. Transfection with PKCδ-speciﬁc siRNA signiﬁcantly decreased
PKCδ protein expression, while transfection with non-targeting
control siRNA (Crtl siRNA) did not affect PKCδ expression (Fig. 4D).
PAMs transfected with PKCδ-speciﬁc siRNA were infected with HV
at 36 h post transfection, and HV replication was analyzed at 24 h
after infection. As shown in Fig. 4E and F, treatment with control
siRNA (Ctrl siRNA) had no effect on PRRSV replication. However,
silencing of PKCδwith PKCδ-speciﬁc siRNA affected both viral RNA
replication (57% reduction) (Fig. 4E) and the virus progeny titers
Fig. 2. PKC inhibitor decreases viral RNA synthesis, protein expression and viral progeny titers. (A) Effect of GF109203X on PRRSV viral RNA synthesis. HP-PRRSV strain HV-
infected PAMs were treated from 0 hpi on with GF109203X (10 μM), and total cellular RNAwas extracted and viral ORF7 RNA copy number was analyzed by quantitative real-
time PCR assay (qPCR). (B) Viral growth curves in PAMs. PAMs were pretreated with DMSO or GF109203X for 1 h and were infected with HV at an MOI of 0.3. At the indicated
time points, virus titers in supernatants were determined. (C) Effect of GF109203X on PRRSV protein expression. HV-infected PAMs were treated from 0 hpi on with
GF109203X and viral GP5 protein expression was analyzed at 24 hpi by Western blot. β-actin was used as a loading control. GF109203X (10 μM) were abbreviated as GF10.
The data represent the mean7standard deviation from three independent experiments. Statistical signiﬁcance was analyzed by t-test; nnPo0.01, nnnPo0.001 and
nnnnPo0.0001.
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(0.7 log 10 decrease, about 5-fold reduction) (Fig. 4F) compared to
that in the control cells (no siRNA). These results suggest that
PKCδ might be activated during PRRSV infection.
One of the hallmarks for PKC activation is the translocation of
these enzymes from the cytoplasm to the membrane or the
cytoskeleton (Mochly-Rosen, 1995). To investigate whether PKCδ
is activated during PRRSV infection, we harvested cytosol and
membrane protein fractions from PAMs infected with PRRSV at
24 hpi or stimulated with phorbol-12-myristate-13-acetate (PMA)
for 10 min, which is known as a speciﬁc activator of cPKC and nPKC
in the PKC family. Western blot analysis showed that upon PRRSV
infection, PKCδ exhibited a signiﬁcant translocation from the
cytosol to the plasma membrane fraction (Fig. 4G), indicating that
PKCδ is activated by PRRSV infection.
Alteration of cytokine gene expression by inhibition of PKC in PAMs
Cytokines play an important role in the modulation of immune
responses and interfere with viral infection. To examine whether
inhibition of PKC affects the transcription of immune-response
genes in PAMs upon HV infection, we analyzed their expression
patterns in the presence or absence of GF109203X (10 μM).
As shown in Fig. 5, inﬂammatory cytokines including IL-1α, IL-
1β, TNF-α and IFN levels were signiﬁcantly reduced in the
presence of GF109203X at 24 hpi. The mRNA levels of toll-like
receptor (TLR) 3 and 7 genes were not affected in the presence of
GF109203X upon HV infection (Fig. 5). Only IL-10 level was slightly
up-regulated by inhibition of PKC in the early time (12 h) after HV
infection and then decreased in the presence of GF109203X at
24 hpi. These data suggest that PKC regulates the cytokine genes
for immune-response during PRRSV infection.
Discussion
Protein kinases C plays an essential role in the replication cycle
of many viruses including HIV, inﬂuenza virus, and Kaposi's
sarcoma-associated herpesvirus (Contreras et al., 2012; Naranatt
et al., 2003; Sieczkarski et al., 2003). In the present study, we
showed that PRRSV replication could be impaired by the broad
PKC inhibitor GF109203X. Subsequently, we found that the inhi-
bitor of the novel isoform PKCδ, rottlerin, signiﬁcantly inhibited
PRRSV replication. Finally, we demonstrated that PKCδ was acti-
vated during PRRSV infection and knockdown of PKCδ with
speciﬁc siRNA could impair PRRSV replication, suggesting that
PKCδ might play an important role in PRRSV replication.
The effect of the PKC inhibitor GF109203X on PRRSV propaga-
tion was examined in two different cell types and with two
different PRRSV strains (Fig. 1A–C). Our results demonstrated that
GF109203X had a general inhibitory effect on PRRSV propagation,
which is independent of cell type and virus strain. Previous study
has shown that 1 μM GF109203X completely inhibits the activa-
tion of conventional PKCs, whereas up to 10 μM GF109203X is
needed to completely block all classes of PKCs (Gunaratne et al.,
2012; Valledor et al., 2000). In this study, we incubated cells with
three different concentrations of GF109203X, and our data showed
that the reduction in PRRSV replication was much more prominent
with 10 μM GF109203X, suggesting that nPKC subgroup is
Fig. 3. PKC inhibitor reduces PRRSV replication at the early stage of infection. (A and B) PRRSV-infected cells were incubated with GF109203X (10 μM) from 1, 0, 2, 6, 12 hpi
or 24 hpi onwards. PRRSV-infected cells treated with porcine IFNα (10 units/ml) from 0 hpi were served as a positive control. Total cellular RNA was extracted and PRRSV
ORF7 RNA level in cells was quantiﬁed and normalized to the control cells (set up as 1) that were treated with DMSO. The relative PRRSV expression level in each sample was
calibrated with the GAPDH copy number. (A) HV in PAMs at 24 hpi. (B) CH-1a in Marc-145 cells at 36 hpi. (C–F) GF109203X inhibits PRRSV entry into Marc-145 cells. (C and
D) Viral binding assay. Marc-145 cells were incubated with CH-1a strain at an MOI of 1 at 4 1C for 2 h in the presence of GF109203X (10 μM) or DMSO. The cells were washed
and then switched to 37 1C to continue culture. The PRRSV ORF7 RNA level in cells (C) and the virus titer in the medium (D) were determined at 36 hpi. (E and F) GF109203X
blocks virus internalization. Marc-145 cells were precooled to 4 1C and incubated with CH-1a (MOI¼1) for 2 h. Unbound virus was removed, and the cells were shifted to
37 1C (this time point was set up as 0 h). GF109203X (10 μM) or DMSO was added at the indicated time following the temperature shift. Five hours after temperature switch,
virus and inhibitor were removed, and the cells were refreshed with medium. The intracellular viral RNA (E) and the virus titer in the culture medium (F) were determined at
36 hpi. The data represent the mean7standard deviation from three independent experiments. Statistical signiﬁcance was analyzed by t-test; nPo0.05, nnPo0.01,
nnnPo0.001 and nnnnPo0.0001.
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important for PRRSV growth. A similar inhibitory effect of PRRSV
replication was observed upon treatment with 5 μM PKCδ speciﬁc
inhibitor rottlerin (Fig. 4A and B). We therefore analyzed the effect
of siRNA-mediated knockdown of PKCδ expression on PRRSV
infectivity (Fig. 4E and F). We found that PKCδ was required for
efﬁcient PRRSV replication, as siRNA-mediated knockdown of
PKCδ reduced PRRSV replication, although we could not exclude
the importance of PKC isoforms other than PKCδ involved in the
replication of PRRSV. Finally, we demonstrated that PRRSV was
able to activate PKCδ in PAMs (Fig. 4G), indicating that activation
of this isoform may be beneﬁcial to PRRSV replication.
PKC regulation of viral replication can act at speciﬁc steps of the
virus replication cycle (Cirone et al., 1990; Contreras et al., 2012;
Park and Baines, 2006; Root et al., 2000; San-Juan-Vergara et al.,
2004). Previous study has identiﬁed that HIV can activate PKC, and
this activation facilitates HIV-1 replication at different steps of its
replicative cycle including entry, early post-entry step, integration
and gene expression (Contreras et al., 2012; Harmon and Ratner,
2008). It has also been reported that inﬂuenza virus requires the
activity of PKC for entry and PKC inhibitors induce an accumula-
tion of virus in late endosomes (Root et al., 2000; Sieczkarski et al.,
2003). However, Mahmoudian et al. reported that PKC inhibitor
Gö6976 was found to not only block viral entry, but also have a
post-entry anti-inﬂuenza viral effect (Mahmoudian et al., 2009). In
agreement with these observations, we showed that PKC was
important at early steps of the viral replication, which may exert
its effect at both the entry and an early post-entry stage of the
virus replication cycle (Fig. 3).
Conventional PKCα and PKCβ were found to be important
negative regulators of the RIG-I-mediated type I IFN response
(Maharaj et al., 2012). Kontny et al. reported that PKC was involved
in the synthesis of pro-inﬂammatory cytokines (TNF-α, IL-1β, and
IL-6) in human monocytes (Kontny et al., 2000, 1999). We also
assessed whether inhibition of PKC activation affected the induction
of cytokine genes by PRRSV in PAMs. Our results indicated that
treatment with GF109203X signiﬁcantly reduced the expression of
infection-induced antiviral cytokine including IFN-α, IFN-β, IL-1α, IL-
1β and TNF-α. In contrast, inhibition of PKC resulted in a slightly
elevation of IL-10 at the early time after HV infection. Therefore,
based on our results, GF109203X-impaired PRRSV replication is not
due to the alteration of antiviral cytokine expressions.
The replication of PRRSV was blocked by 10 μM GF109203X or
5 μM rottlerin, but there was no obvious cellular toxicity observed
Fig. 4. PKCδ is required for PRRSV replication in PAMs. (A and B) PAMs were pretreated for 1 h with GF109203X, rottlerin (PKCδ inhibitor), Gö6976 (cPKC inhibitor) or DMSO
at indicated concentrations and then infected with HP-PRRSV strain HV. (A) PRRSV ORF7 RNA level at 24 hpi in cells was determined by qPCR and (B) the virus titers in the
supernatants were measured. (C) Effect of rottlerin on PAMs viability compared to DMSO-treated cells (set up as 1) was determined using MTT assay. (D–F) RNAi-mediated
knockdown of PKCδ reduces PRRSV replication. PAMs were transfected with a nontargeting control siRNA (Ctrl) or siRNA targeting PKCδ. (D) PKCδ level was examined by
Western blot using antibody against PKCδ. (E) PRRSV ORF7 RNA level at 24 hpi in cells transfected with the siRNAs, which were infected with HV at an MOI of 0.3 at 36 h
post-transfection with the siRNAs. (F) The experiments were performed as described for panel D and virus titers in the supernatant were determined at 24 hpi. (G) PRRSV
infection activates PKCδ is determined by analyzing PKCδ translocate from cytoplasm to plasma membrane. PAMs were mock-infected or infected with HV at an MOI of
0.3 for 24 h. Cells treated with PMA (100 nM) for 15 min were used as a positive control. Cell cytoplasm and plasma membrane fractions were isolated and detected by
Western blot with PKCδ and β-actin antibodies. The data represent the mean7standard deviation from three independent experiments. Statistical signiﬁcance was analyzed
by t-test; nPo0.05, nnPo0.01, nnnPo0.001 and nnnnPo0.0001.
Fig. 5. Inhibition of PKC regulates transcript levels of immune-related genes during
PRRSV infection. PAMs were pretreated with GF109203X (10 μM) or DMSO for 1 h
and infected with HP-PRRSV strain HV (MOI¼0.3). Total RNA was extracted at
12 hpi (white bar) and 24 hpi (gray bar) from lysates of the infected cells and the
mRNA level of each cytokine gene was assessed by qPCR and normalized to GAPDH.
Relative expression (fold changes) was compared with HV-infected cells without
GF109203X (set up as 1). The data represent the mean7standard deviation from
three independent experiments.
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at the doses used in our experiments. Thus, we assume the reason
that inhibition of PKC impairs PRRSV replication is not due to the
cytotoxic effect of the inhibitors on cells. PKC has been demon-
strated to play a pivotal role in cell survival and proliferation
(Griner and Kazanietz, 2007), and PRRSV infection triggers apop-
tosis in vitro and in vivo (Ma et al., 2013; Sur et al., 1998). In most
cell types, PKCδ is pro-apoptotic and negatively regulates prolif-
eration (Zhao et al., 2012), although in a few cases, it can mediate
mitogenic responses (Jackson and Foster, 2004). Successful viral
replication is critically dependent on the maintenance of pro-
survival and anti-apoptotic signals in host cells. Moreover, PRRSV
N protein is modiﬁed by phosphorylation and the protein kinase
motif for protein kinase C (PKC) (S-X-R) is found in N protein
amino acid sequence (Wootton et al., 2002) even though the
functional roles for their phosphorylation is poorly understood
(Kimman et al., 2009). Therefore, a detailed understanding of the
inhibition of PKC on PRRSV replication remains an important area
for further investigation.
In summary, our study demonstrates that PKC plays an impor-
tant role in PRRSV replication. Inhibition of PKC signiﬁcantly
impairs PRRSV replication by exerting its effect at the early stage
of infection. Moreover, we also identify that novel PKCδ isoform is
required for PRRSV replication. The role of PKC in PRRSV replica-
tion will help us to understand the molecular mechanism of PRRSV
infection.
Materials and methods
Cells and viruses
Porcine alveolar macrophages (PAMs) were obtained by post-
mortem lung lavage of 8-week-old speciﬁc pathogen free pigs, and
maintained in RPMI 1640 supplemented with 10% FBS and
penicillin/streptomycin. Marc-145 cells, a PRRSV-permissive cell
line derived from MA-104 cells (Kim et al., 1993), were maintained
in FBS-DMEM supplemented with penicillin/streptomycin.
PRRSV strains, HV (GenBank accession no. JX317648), a HP-
PRRSV strain isolated from a pig farm with an atypical PRRS
outbreak in Jiangxi Province, China, and CH-1a (GenBank acces-
sion, AY032626), the ﬁrst type 2 PRRSV strain isolated in China,
were propagated and titrated on PAMs or Marc-145 cells. Brieﬂy,
PRRSV was serially diluted 10-fold in RPMI 1640 or DMEM to
infect 5104 PAMs or Marc-145 cells in 96-well plates. The virus
titer of PRRSV infection was determined 36 h postinfection (hpi)
using immunoﬂuorescent staining for the PRRSV N protein. Virus
titer was calculated using Reed–Muench method, and expressed as
tissue culture infective dose 50% (TCID50).
MTT assay
Cell viability in the presence of inhibitor was determined by the
MTT (3-(4,5)-dimethylthiahiazo(-z-y1)-3,5-di-phenytetrazolium-
romide) (Sigma) assay. PAMs or Marc-145 cells in 96-well plates
were incubated with 100 μL growth medium containing dimethyl
sulfoxide (DMSO) or different concentrations of the inhibitor for
48 h at 37 1C. Next, 20 μL MTT solution (5 mg/ml) was added to
each well, and the cells were incubated at 37 1C for another 4 h
until the medium was replaced with 200 μL DMSO to dissolve the
crystals. And then, the absorbance of 495 nm was measured by an
enzyme-linked immunosorbent assay reader. The 50% cytotoxic
concentration (CC50) was analyzed by GraphPad Prism (Graph-Pad
Software, San Diego, CA).
Indirect immunoﬂuorescence assay (IFA)
The cells were washed with phosphate-buffered saline (PBS)
and ﬁxed with cold methanol–acetone (1:1) at 4 1C for 10 min, and
then blocked with 5% normal goat serum for 30 min at room
temperature. After blocking, cells were stained with anti-PRRSV N
protein monoclonal antibody SDOW17 (1:10,000; Rural Technolo-
gies) at 37 1C for 1 h. After three washes with PBS, cells were
incubated with FITC-conjugated anti-mouse immunoglobulin G
(HþL) (1:200) at 37 1C for 1 h and examined by ﬂuorescence
microscopy using Leica Microsystems CMS GmbH.
Quantitative real-time PCR (qPCR)
Total RNA was extracted from PAMs or Marc-145 cells with
TRIzol (Invitrogen) following manufacturer's instructions and
reverse-transcribed to cDNA using M-MLV Reverse Transcriptase
(Promega). Quantitative real-time PCR was performed to deter-
mine the PRRSV loads and the levels of cytokines in cells collected
from PRRSV-infected PAMs or Marc-145 cells using ViiA™ 7 real-
time PCR System (Applied Biosystems) and FastSYBR Mixture
(CWBIO). For the absolute quantiﬁcation, a plasmid containing
PRRSV ORF7 sequence (Han et al., 2009) was used to generate a
standard curve, and then RNA copies in all samples were calcu-
lated by comparing with the standard curve. Relative expression
levels were analyzed using the ΔΔCt method (Bookout et al.,
2006) and GAPDH was set up as endogenous control. The primers
used for qPCR ampliﬁcation are listed in Table 1.
Extraction of membrane and cytoplasmic proteins
Cell plasma membrane and cytoplasmic fractions were isolated
from PAMs using Cell Fractionation kit (#9038, CST) according to
the manufacturer's instructions with minor modiﬁcation. Brieﬂy,
following stimulation, cells were washed and resuspended in
Cytoplasm Isolation Buffer (CIB). The cell suspensions were
vortexed for 10 s, incubated on ice for 10 min, and then centri-
fuged (500g for 5 min at 4 1C). The supernatants were collected as
cytoplasmic fraction. Pellets were resuspended in Membrane
Isolation Buffer (MIB) and vortexed for 15 s. Following incubation
on ice for 10 min, cell debris was removed by centrifugation, and
Table 1
Quantitative RT-PCR primers.
Name Sequence (50-30)
ORF7-F AATAACAACGGCAAGCAGCA
ORF7-R GCACAGTATGATGCGTCGGC
IL-10-F CGGCGCTGTCATCAATTTCTG
IL-10-R CCCCTCTCTTGGAGCTTGCTA
IFN-α-F CTGCTGCCTGGAATGAGAGCC
IFN-α-R TGACACAGGCTTCCAGGTCCC
IFN-β-F AGCACTGGCTGGAATGAAACCG
IFN-β-R CTCCAGGTCATCCATCTGCCCA
Il-1α-F TTGAAGACCTGAAGAACTGCTACA
Il-1α-R GCCATCACCACACTGTCCTT
TLR3-F GGACTTTGAGGCAGGTGCCCTT
TLR3-R TGGTGCACCTTGAATCTTTTGCAC
TLR7-F TGCGACGCTGTGTGGCTTGT
TLR7-R TGGCCCTTGTGTGCTCCTGG
IL-1β-F TCTGCCCTGTACCCCAACTG
IL-1β-R CCCAGGAAGACGGGCTTT
TNF-α-F ACCACGCTCTTCTGCCTACTGC
TNF-α-R TCCCTCGGCTTTGACATTGGCTAC
PKCδ-F GCAGGGATTAAAGTGTGAAG
PKCδ-R AACCTCCGACTCTGACTTTC
GAPDH-F CCTTCCGTGTCCCTACTGCCAAC
GAPDH-R GACGCCTGCTTCACCACCTTCT
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the supernatants containing membrane-associated proteins were
kept at 80 1C.
Western blotting
Equal amounts of proteins were separated on SDS-PAGE gel and
then transferred to PVDF membranes (Millipore, USA). The mem-
branes were blocked for 1 h at room temperature in blocking buffer
PBST (PBS containing 0.5% Tween-20) containing 5% skim milk
powder to prevent nonspeciﬁc binding. After blocking, the mem-
branes were incubated with speciﬁc primary antibodies against GP5
(1:4000; made in our lab) or β-actin (1:5000; Sigma) for 1 h at room
temperature or with PKC-delta (PKCδ) (1:500; Santa Cruz Biotech-
nology) overnight at 4 1C. The membranes were washed three times
with PBST and then incubated for 1 h at room temperature with the
appropriate HRP-conjugated secondary antibodies diluted in block-
ing buffer. Immunoreactive bands were visualized by enhanced
chemiluminescence (ECL) reagent according to the manufacturer's
instructions.
PRRSV binding assay
For binding assay, Marc-145 cells were inoculated with medium
containing CH-1a (MOI¼1) and DMSO or GF109203X at 4 1C for 2 h.
Then, unbound virus/inhibitor was removed by washing three times
with cold PBS and the medium was replaced with 2% FBS–DMEM.
The cells were then switched to 37 1C to culture for another 34 h. The
total cellular RNA was extracted to analyze PRRSV ORF7 RNA level
and supernatants were harvested for virus titration.
PRRSV internalization assay
For internalization assay, Marc-145 cells were incubated with
CH-1a (MOI¼1) at 4 1C for 2 h to permit binding. Next, the
medium was removed and cells were washed 3 times with cold
PBS to remove unattached virus particles. Then, fresh medium was
added and cells were switched to 37 1C (this time point was set up
as 0 h) to allow virus entry. GF109203X (10 μM) was then added at
0 or 3 h following temperature shift. At 5 h following temperature
switch, the cells were carefully washed with PBS and then
continued to be cultured with fresh medium at 37 1C. At 36 hpi,
PRRSV ORF7 RNA level in cells and the virus titer in the medium
were determined.
siRNA and transfection
siRNA duplexes (siRNAs) were synthesized and puriﬁed by
Genepharma. siRNA sequences are as follows: for PKCδ (PKCδ
siRNA), 50-CCACGAGUUUAUCGCCACCTT-30 (Choi et al., 2010); for
nontargeting control siRNA (Ctrl siRNA), 50-UUCUCCGAACGUGUCAC-
GUTT-30. Transient transfection with siRNA was carried out using
HiPerFect (Qiagen) according to the manufacturer's recommenda-
tions at a ﬁnal concentration of 50 nM.
Statistical analysis
All experiments were performed at least three independent
replicates. Results were analyzed using Graph-Pad Prism Software,
and differences were evaluated by Student's t test. A P value of less
than 0.05 was considered to be signiﬁcant.
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